Vaxart begins early-stage trial of oral COVID-19 vaccine candidate

Vaxart Inc said on Tuesday it had begun an early-stage study testing its oral tablet COVID-19 vaccine candidate, which the drug developer hopes would be a viable alternative to injectable vaccines.